UnitedHealth Group Incorporated $UNH Stock: Sumitomo Mitsui DS Asset Management Company Ltd Increases Holdings

Sumitomo Mitsui DS Asset Management Company Ltd increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 0.8% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 374,797 shares of the healthcare conglomerate’s stock after acquiring an additional 2,881 shares during the quarter. UnitedHealth Group comprises approximately 0.9% of Sumitomo Mitsui DS Asset Management Company Ltd’s holdings, making the stock its 19th largest holding. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in UnitedHealth Group were worth $137,580,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Bank of Stockton raised its holdings in UnitedHealth Group by 12.9% in the 3rd quarter. Bank of Stockton now owns 2,395 shares of the healthcare conglomerate’s stock valued at $879,000 after acquiring an additional 274 shares in the last quarter. CWA Asset Management Group LLC lifted its position in shares of UnitedHealth Group by 5.3% in the 3rd quarter. CWA Asset Management Group LLC now owns 5,273 shares of the healthcare conglomerate’s stock worth $1,936,000 after acquiring an additional 267 shares during the period. Secure Asset Management LLC acquired a new stake in shares of UnitedHealth Group during the 3rd quarter worth approximately $886,000. Maia Wealth LLC increased its position in shares of UnitedHealth Group by 17.7% during the third quarter. Maia Wealth LLC now owns 14,252 shares of the healthcare conglomerate’s stock valued at $5,232,000 after purchasing an additional 2,148 shares during the period. Finally, Tanager Wealth Management LLP bought a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $229,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other UnitedHealth Group news, CEO Patrick Conway sold 1,169 shares of the business’s stock in a transaction dated Friday, August 21st. The shares were sold at an average price of $390.00, for a total value of $455,910.00. Following the transaction, the chief executive officer directly owned 15,328 shares in the company, valued at $5,977,920. The trade was a 7.09% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 0.19% of the stock is currently owned by company insiders.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: Q3 earnings beat and raised outlook: UnitedHealth reported adjusted earnings of $4.69 per share versus the $4.14 consensus estimate, while revenue of $112.7 billion also exceeded expectations. Management raised its 2026 adjusted EPS outlook to at least $20.50, reinforcing investor confidence in operating execution and helping drive renewed interest in the shares. UnitedHealth Group Has The Market Asking A Bigger Question
• Positive Sentiment: Improving investor sentiment: Recent gains have followed the earnings beat and guidance increase, with analysts and investors reassessing medical-cost trends and the company’s ability to achieve its longer-term growth targets. Some coverage also points to potential efficiency gains from artificial intelligence and UnitedHealth’s diversified business model. Is UnitedHealth Group Stock a Buy After Another Solid Quarter?
• Neutral Sentiment: Healthcare-sector interest: UnitedHealth’s results are supporting interest in healthcare ETFs that include UNH, although diversified funds may reduce exposure to company-specific and Medicaid-related risks. A potentially divided government after the midterm elections could also be broadly favorable for healthcare stocks, but the policy outcome remains uncertain. Healthcare ETFs to Buy as UnitedHealth Beats on Q3 Earnings
• Negative Sentiment: Valuation concerns: One analyst downgraded UnitedHealth from “strong buy” to “buy,” arguing that the stock appears fairly valued near 20 times forward earnings. The view suggests the recent rally may already reflect much of the earnings recovery, making additional gains more dependent on sustained execution. UnitedHealth Rating Downgrade
• Negative Sentiment: Coverage and enrollment pressure: A sharp decline in individual-market enrollment and reports that millions of seniors may lose Medicare Advantage plans in 2027 highlight regulatory, membership and pricing risks for health insurers. These developments could pressure growth and increase uncertainty around future medical costs and retention. Health Insurance Market Enrollment Decline

UnitedHealth Group Stock Performance

UnitedHealth Group stock opened at $406.99 on Tuesday. The firm has a market capitalization of $365.31 billion, a P/E ratio of 23.24, a P/E/G ratio of 1.45 and a beta of 0.60. The stock has a fifty day moving average price of $387.04 and a two-hundred day moving average price of $386.47. UnitedHealth Group Incorporated has a 52-week low of $255.96 and a 52-week high of $461.62. The company has a debt-to-equity ratio of 0.66, a current ratio of 0.74 and a quick ratio of 0.78.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, October 13th. The healthcare conglomerate reported $4.69 EPS for the quarter, beating the consensus estimate of $4.14 by $0.55. UnitedHealth Group had a net margin of 3.53% and a return on equity of 17.95%. The company had revenue of $112.70 billion for the quarter, compared to the consensus estimate of $111.31 billion. During the same quarter in the previous year, the company earned $2.59 EPS. The firm’s revenue for the quarter was down .4% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 20.500- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 20.64 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Monday, September 14th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 53.00%.

Wall Street Analysts Forecast Growth

Several research analysts recently commented on the company. DA Davidson set a $512.00 target price on UnitedHealth Group in a research report on Tuesday, July 21st. Truist Financial lifted their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the stock a “buy” rating in a research note on Tuesday, July 14th. Evercore boosted their price target on shares of UnitedHealth Group from $400.00 to $480.00 and gave the company an “outperform” rating in a report on Tuesday, July 7th. The Goldman Sachs Group increased their price objective on shares of UnitedHealth Group from $435.00 to $490.00 and gave the company a “buy” rating in a research note on Friday, July 17th. Finally, Sanford C. Bernstein reduced their price objective on shares of UnitedHealth Group from $512.00 to $500.00 and set an “outperform” rating for the company in a report on Wednesday, October 14th. Twenty investment analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $463.57.

UnitedHealth Group Profile

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care company that provides health insurance coverage, health care services, pharmacy services and health technology. Its businesses serve individuals, employers, government programs, health care providers and other organizations, primarily in the United States.

The company operates through two principal businesses. UnitedHealthcare offers health benefit plans and related services for employers, individuals, families and government-sponsored programs, including Medicare and Medicaid.